Search

everythinglearnresearchcommunity

for

Search:↓

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

A teenager had both alopecia areata and vitiligo, which are rare to occur together.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

The conclusion is that in the Indian subcontinent, socioeconomic status, stress, and family structure affect the severity of alopecia areata, and its psychological impact is generally mild or moderate.

Alopecia areata in infants may be more common than previously thought.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

The document concludes that various hair and scalp disorders in children have specific treatments and proper diagnosis is essential.

Cyclosporin effectively and safely treated skin diseases in three pets with no side effects.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

A tick bite caused temporary hair loss in a man, which is a rare condition that usually gets better within 3 months.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

About 40% of women by age 60 experience significant hair loss, often due to androgenetic alopecia, with treatments like minoxidil available and hope for future cures.

The document explains how to claim CME credit by diagnosing and treating hair loss conditions in two patient cases.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

A 10-year-old girl with Fox Fordyce disease improved with treatment, suggesting the disease can occur before puberty and might be underdiagnosed in young girls.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

Fox Fordyce disease might be more common in prepubertal girls than thought and can be managed with treatment.

Fox Fordyce disease can occur in prepubertal girls and may be underdiagnosed.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

Alopecia areata often starts around age 23, can be permanent in 30% of cases, and treatments are usually temporary.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

A woman with type 2 diabetes developed alopecia areata, suggesting a link between the two autoimmune conditions.

Anterolateral leg alopecia is a benign, nonprogressive hair loss condition on the lower legs that is not well understood and may resolve on its own.

Minoxidil showed a 30% success rate for hair growth in a study, and various skin treatments were effective, but some had limitations or side effects.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Alopecia areata causes patchy hair loss and involves immune system disruptions.